ACE2 is a negative regulator of profilin-1 expression and collagen production in cultured adult murine cardiomyocytes

haiyan jin,jiuchang zhong,bei song,gavin y oudit,yulin li,manfred schuster,dingliang zhu,pingjin gao,hans loibner,josef m penninger
DOI: https://doi.org/10.1016/j.ijcard.2011.08.794
IF: 4.039
2011-01-01
International Journal of Cardiology
Abstract:A newly-discovered angiotensin-converting enzyme 2 (ACE2) is a monocarboxy peptidase capable of metabolizing angiotensin (Ang) II to produce Ang-(1-7), which has been shown to exert vasodilatory/antiprofibrotic effects via its Mas receptor. In this work, we examined the impact of human recombinant ACE2 (hrACE2) on Ang II effects in cultured cardiomyocytes. Adult murine left ventricular cardiomyocytes were isolated and cultured. The Mas receptor antagonist A779 (10 μM) and hrACE2 (0.2 or 2 mg/mL) were added to the cardiomyocytes for 2 h and 30 min prior to 30-min exposure of Ang II (100 nM), respectively. RNA and phosphorylation levels of cells were determined by TaqMan real-time PCR and western blot, respectively. Real-time PCR analyses exhibited a marked increase in profilin-1 expression in response to Ang II in cardiomyocytes which was blocked by hrACE2 in a dose-dependent manner (n=6, P<0.01, respectively). Pre-incubation with A779 largely blocked the hrACE2-mediated suppression of profilin-1 expression in response to Ang II. In addition, treatment with hrACE2 reduced strikingly Ang II-induced mRNA expression of pro-collagen type Iα, pro-collagen type IIIα, matrix metalloproteinase 9 in cultured cardiomyocytes (n=5~6, P<0.05, respectively). The enhanced phosphorylation level of extracellular signal-regulated kinases (ERK) 1/2, but not p38-mitogen activated protein kinase, in cardiomyocytes treated with Ang II was partially prevented by rhACE2 which was reversed by co-treatment with A779 (n=5, P<0.05, respectively). In conclusion, ACE2 exerts protective effects on cardiomyocytes by the modulation of profilin-1 expression and collagen production which are mediated in part by the promotion of the Ang-(1-7)-Mas signaling, implying that the ACE2-Ang-(1-7)-Mas axis may represent new possibilities for developing novel therapeutic strategies for the prevention and treatment of hypertension and cardiovascular diseases.
What problem does this paper attempt to address?